Literature DB >> 12677466

Animal models for therapeutic embolization.

Patricia L Moreira1, Yuehuei H An.   

Abstract

Embolization techniques have been performed in different animals to accumulate basic data before a clinical trial. Choosing the right embolization model for a specific project is critical. However, there are several variables when defining the best model for embolization research such as the size of the animal to be used, the target organs, the route of introducing the embolization agent, and the feasible methods of evaluation. Commonly used research animals for endovascular embolization include rabbits, dogs, and rats. Frequently used target organs are the kidney and the liver. Most models use a transcatheter for introducing the embolus and occasionally open surgery and direct arterial injection are used. Basic methods of evaluation are straightforward, and commonly include macro observation of the embolized organs, angiogram, and histology. This article concisely reviews the available animal models and their evaluation for embolization research to help researchers to choose the appropriate model.

Entities:  

Mesh:

Year:  2003        PMID: 12677466     DOI: 10.1007/s00270-003-2632-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  5 in total

1.  Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.

Authors:  Rafael Duran; Sahar Mirpour; Vasily Pekurovsky; Shanmugasundaram Ganapathy-Kanniappan; Cory F Brayton; Toby C Cornish; Boris Gorodetski; Juvenal Reyes; Julius Chapiro; Rüdiger E Schernthaner; Constantine Frangakis; MingDe Lin; Jessica D Sun; Charles P Hart; Jean-François Geschwind
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

2.  Effect of transcatheter intraarterial therapies on the distribution of Doxorubicin in liver cancer in a rabbit model.

Authors:  Bin Liang; Fu Xiong; Hanping Wu; Yong Wang; Xiangjun Dong; Shaofeng Cheng; Gansheng Feng; Guofeng Zhou; Bin Xiong; Huimin Liang; Xiangwen Xia; Chuansheng Zheng
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

3.  Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.

Authors:  Marcus Caine; Ting Chung; Hugh Kilpatrick; Zainab Bascal; Sean Willis; Yiqing Tang; Thierry de Baere; Matthew Dreher; Andrew Lewis
Journal:  Theranostics       Date:  2019-07-28       Impact factor: 11.556

4.  Creation of an ex-vivo bovine kidney flow model for testing embolic agents: work in progress.

Authors:  Luis Garza; Ryan Bitar; Barrett O'Donnell; Matthew Parker; Carlos Ortiz; Charles Hyman; John Walker; Ho-Young Song; Jorge Lopera
Journal:  CVIR Endovasc       Date:  2021-02-03

5.  Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors.

Authors:  Feng Dai; Xiuming Zhang; Wenrong Shen; Jun Chen; Liucheng Liu; Gejun Gao
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.